News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
123 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17567)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (192)
2 (123)
5 (144)
6 (142)
7 (169)
8 (188)
9 (100)
12 (136)
13 (139)
14 (123)
15 (130)
16 (48)
19 (83)
20 (71)
21 (97)
22 (50)
23 (91)
26 (100)
27 (110)
28 (134)
29 (108)
30 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
Press Releases
FDA Approves AChEI ALPHA-1062 for Alzheimer’s Disease Treatment
On July 29, 2024, the U.S. FDA approved Alpha Cognition Inc.'s ALPHA-1062 (Zunveyl®), an Acetylcholinesterase (AChE) inhibitor, for treating mild-to-moderate Alzheimer’s disease.
August 2, 2024
·
2 min read
Press Releases
FDA Accepted PD-L1 Inhibitor Durvalumab for the Treatment of Endometrial Cancer
On June 14, 2024, the U.S. FDA approved AstraZeneca’s Durvalumab (IMFINZI®) for primary advanced or recurrent endometrial cancer with mismatch repair deficiency.
August 2, 2024
·
2 min read
Press Releases
Migraine Drugs Market Size to Reach USD 6.3 Billion by 2032, Impelled by Advancements in Treatment Processes
August 2, 2024
·
11 min read
Press Releases
Pulmonary Arterial Hypertension Drugs Market Size to Reach USD 11.6 Billion by 2032, Impelled by Increasing Pulmonary Disorders
August 2, 2024
·
11 min read
Press Releases
Nasal Polyps Market Size to Reach USD 109.0 Million by 2034, Impelled by Adoption of Biologic Therapies
August 2, 2024
·
12 min read
Press Releases
Multiple Sclerosis Therapies Market Size to Reach USD 37.8 Billion by 2032, Impelled by Technological Advancements
August 2, 2024
·
10 min read
Press Releases
Europe Medical Cannabis Market Size to Reach USD 11,093.7 Million by 2032, Impelled by the Need for Pain Management
August 2, 2024
·
10 min read
Press Releases
Acromegaly Market to Reach a CAGR of 8.1% during 2024-2034, Impelled by Innovative Treatment Options
August 2, 2024
·
13 min read
Press Releases
Chronic Lower Back Pain Market Size to Reach USD 10.0 Billion by 2034, Impelled by the Widespread Adoption of Massage Therapies
August 2, 2024
·
10 min read
Press Releases
Diffuse Large B-Cell Lymphoma Market Size to Reach USD 5,257.7 Million by 2034, Impelled by Increased Geriatric Population
August 2, 2024
·
11 min read
Previous
6 of 13
Next
